Form 4 Tracker
SOPHiA GENETICS SA
SOPH

109 insider filings · Latest: Aug 13, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 12, 2026Aug 14 8:40 PMPhilippe MenuChief Medical Officer
Sale
5,000$7.52$37.6K218,387(D)

View →

Aug 13, 2026Aug 14 8:40 PMZhenyu XuChief Scientific Officer
Sale
4,000$7.52$30.1K586,887(D)

View →

Aug 7, 2026Aug 10 9:14 PMAbhimanyu VermaChief Technology Officer
Sale
5,000$7.60$38.0K182,171(D)

View →

Aug 10, 2026Aug 10 9:14 PMJurgi CamblongDirector, Executive Chairman
Sale
8,500$7.61$64.7K3,444,322(D)

View →

Aug 7, 2026Aug 10 9:14 PMJurgi CamblongDirector, Executive Chairman
Sale
20,000$7.23$144.5K3,452,822(D)

View →

Aug 7, 2026Aug 7 9:35 PMZhenyu XuChief Scientific Officer
Sale
17,000$7.29$123.9K590,887(D)

View →

Aug 5, 2026Aug 7 9:35 PMZhenyu XuChief Scientific Officer
Sale
3,000$7.00$21.0K600,887(D)

View →

Aug 7, 2026Aug 7 8:35 PMZHENYU XU
Proposed Sale
22,000$6.69$147.2K

View →

Aug 7, 2026Aug 7 8:33 PMJURGI CAMBLONG
Proposed Sale
20,000$6.69$133.8K

View →

Aug 4, 2026Aug 5 8:14 PMAbhimanyu VermaChief Technology Officer
Sale
5,000$6.95$34.8K187,171(D)

View →

Aug 4, 2026Aug 5 8:14 PMJurgi CamblongDirector, Executive Chairman
Sale
20,000$6.92$138.4K3,472,822(D)

View →

Aug 4, 2026Aug 5 8:13 PMZhenyu XuChief Scientific Officer
Sale
10,000$6.92$69.2K600,887(D)

View →

Aug 4, 2026Aug 4 8:37 PMJURGI CAMBLONG
Proposed Sale
20,000$5.69$113.8K

View →

Aug 4, 2026Aug 4 8:37 PMZHENYU XU
Proposed Sale
10,000$5.69$56.9K

View →

Jul 27, 2026Jul 28 8:03 PMPhilippe MenuChief Medical Officer
Sale
5,000$5.66$28.3K223,387(D)

View →

Jul 21, 2026Jul 22 8:01 PMJurgi CamblongDirector, Executive Chairman
Sale
20,000$6.63$132.7K3,492,822(D)

View →

Jul 20, 2026Jul 22 8:01 PMJurgi CamblongDirector, Executive Chairman
Sale
24,381$6.29$153.4K3,512,822(D)

View →

Jul 21, 2026Jul 21 8:24 PMJURGI CAMBLONG
Proposed Sale
37,000$6.33$234.2K

View →

Jul 20, 2026Jul 20 8:15 PMJURGI CAMBLONG
Proposed Sale
24,381$5.87$143.1K

View →

Jul 13, 2026Jul 14 8:02 PMPhilippe MenuChief Medical Officer
Sale
5,000$5.70$28.5K228,387(D)

View →

Page 1 of 13

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 2, 2026Apr 3 10:59 AMAbhimanyu VermaChief Technology Officer
Grant/Award
119,760$5.04119,760(D)

View →

Apr 2, 2026Apr 3 10:59 AMRoss MukenPresident
Grant/Award
628,743$5.04628,743(D)

View →

Apr 2, 2026Apr 3 10:59 AMPhilippe MenuChief Medical Officer
Grant/Award
164,671$5.04164,671(D)

View →

Apr 2, 2026Apr 3 10:59 AMZhenyu XuChief Scientific Officer
Grant/Award
164,671$5.04164,671(D)

View →

Apr 2, 2026Apr 3 10:59 AMJurgi CamblongDirector, Chief Executive Officer
Grant/Award
628,743$5.04628,743(D)

View →

Apr 2, 2026Apr 3 10:59 AMKevin PuylaertChief Sales Officer
Grant/Award
82,335$5.0482,335(D)

View →

Apr 2, 2026Apr 3 10:59 AMGeorge CardozaChief Financial Officer
Grant/Award
164,671$5.04164,671(D)

View →

Apr 2, 2026Apr 3 10:58 AMManuela ValenteChief People Officer
Grant/Award
104,790$5.04104,790(D)

View →

Apr 2, 2026Apr 3 10:58 AMWell Daan VanChief Legal Officer
Grant/Award
142,216$5.04142,216(D)

View →

← Previous

Page 2 of 2